BeOne Medicines Ltd (6160N) Ownership - Who Owns BeOne Medicines Ltd?
BeOne Medicines Ltd (6160N) Ownership Overview
- 4.46% Mutual Funds
- <0.01% Other Institutional Investors
- 5.76% ETFs
- 89.78% Public Companies and Individual Investors
The ownership structure of BeOne Medicines Ltd (MX:6160N) stock is a mix of institutional, retail, and individual investors. Approximately 10.22% of the company’s stock is owned by Institutional Investors, and 89.78% is owned by Public Companies and Individual Investors.
The ownership structure of BeOne Medicines Ltd (MX:6160N) stock is a mix of institutional, retail, and individual investors. Approximately 10.22% of the company’s stock is owned by Institutional Investors, and 89.78% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ishares | 34,910,118 | Institution | 2.45% | ― |
| Vanguard | 28,644,695 | Institution | 2.01% | ― |
| Vanguard International Equity Index Funds | 13,883,600 | Institution | 0.97% | ― |
| Vanguard Star Funds | 11,979,368 | Institution | 0.84% | ― |
| Delaware Group Global & International Funds | 4,847,100 | Institution | 0.34% | ― |
| Fidelity Salem Street Trust | 3,821,409 | Institution | 0.27% | ― |
| Xtrackers | 3,491,514 | Institution | 0.24% | ― |
| Baillie Gifford Funds | 3,350,004 | Institution | 0.23% | ― |
| Amundi | 3,021,754 | Institution | 0.21% | ― |
| Hartford Mutual Funds Ii, Inc | 2,994,400 | Institution | 0.21% | ― |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard International Equity Index Funds | 13,883,600 | Institution | 0.97% | ― |
| Vanguard Star Funds | 11,979,368 | Institution | 0.84% | ― |
| Delaware Group Global & International Funds | 4,847,100 | Institution | 0.34% | ― |
| Fidelity Salem Street Trust | 3,821,409 | Institution | 0.27% | ― |
| Baillie Gifford Funds | 3,350,004 | Institution | 0.23% | ― |
| Hartford Mutual Funds Ii, Inc | 2,994,400 | Institution | 0.21% | ― |
| New Perspective Fund | 2,871,700 | Institution | 0.20% | ― |
| New World Fund Inc | 2,827,700 | Institution | 0.20% | ― |
| Fidelity Investment Trust | 2,697,223 | Institution | 0.19% | ― |
| Tiaa-cref Funds | 2,596,052 | Institution | 0.18% | ― |
FAQ
What percentage of BeOne Medicines Ltd (MX:6160N) stock is held by institutional investors?
According to the latest TipRanks data, approximately 10.22% of BeOne Medicines Ltd (MX:6160N) stock is held by institutional investors: 4.46% by mutual funds, 5.76% by ETFs and <0.01% by other institutional investors.
What percentage of BeOne Medicines Ltd (MX:6160N) stock is held by retail investors?
According to the latest TipRanks data, approximately 89.78% of BeOne Medicines Ltd (MX:6160N) stock is held by public companies and individual investors.
Who owns the most shares of BeOne Medicines Ltd (MX:6160N)?
iShares owns the most shares of BeOne Medicines Ltd (MX:6160N).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
